Original ResearchPublished 21 May 2026Tolazoline, an alpha-adrenergic antagonist, may also block xylazine at off-target sites as inferred from molecular dockingGiuseppe Floresta · Vincenzo Patamia · Alberto Granzotto · Davide Arillotta · Gabriele Duccio Papanti · Amira Guirguis · John M. Corkery · Giovanni Martinotti · Stefano L. Sensi · Fabrizio SchifanoFrontiers in Chemical Biologydoi 10.3389/fchbi.2026.1806456
Adolescent MedicinePublished 30 June 2025Promoting recovery capital among college students in recovery on a campus developing a collegiate recovery programMichael J. Broman · Jhuma Acharya · Elizabeth A. Bowen · Emily Pasman · Erin Marks · Jeffrey G. Kuentzel · Stella M. ReskoFrontiers in Adolescent Medicinedoi 10.3389/fradm.2025.1602144
